There were 1,064 press releases posted in the last 24 hours and 185,784 in the last 365 days.
Asia-Pacific is anticipated to be the fastest growing pharmaceutical excipients market, for organic and inorganic chemicals, in terms revenue during forecast
PORTLAND, OREGON, UNITED STATE, March 9, 2022 /EINPresswire.com/ -- In the organic chemicals category, carbohydrates generated the highest revenue and is expected to dominate till 2020. Pharmaceuticals Excipients Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $6.4 billion by 2020, registering a CAGR of 7.6% during the period 2015-2020. North America and Europe will continue to be the lead revenue generating economies through 2020. These regions collectively accounted for about three-fourth of share in the global pharmaceutical excipients market in 2015.
Download Sample Report : https://www.alliedmarketresearch.com/request-sample/1053
Factors that drive the global pharmaceutical excipients market are rising demand for pharmaceutical drugs, increasing popularity of functional excipients, drug pipeline, development of novel excipients, and increasing generic drugs market caused by expiration of various bestseller drugs patents. Factors that are likely to impede the market growth include, supply chain issues, high market fragmentation, and implementation of stringent regulations.
Key findings of Pharmaceutical Excipients Market:
Binders generated the highest revenue accounting for about two-seventh of the overall market revenue in 2015. In the inorganic chemical category, halites segment is projected to grow at the highest CAGR of 29.2% during the forecast period. Calcium phosphate (inorganic chemical) segment is projected to reach $539.9 million by 2020 at a CAGR of 10.5%. In the organic chemicals category, carbohydrates generated the highest revenue and is expected to dominate till 2020. Disintegrates segment is projected to grow at a highest CAGR of 12.6% from 2015 to 2020. Proteins segment (Petrochemicals category) generated highest revenue in 2015; however, mineral hydrocarbons segment is expected to grow at the highest CAGR of 7.0% during the period under consideration.
The key companies included in the report are Ashland, Inc., BASF SE, Associated British Foods Plc, Akzo Nobel N.V., The Dow Chemical Company, Evonik, Merck, J.M. Huber Corporation, Covidien Plc, and Archer Daniels Midland.
PHARMACEUTICAL EXCIPIENTS MARKET KEY SEGMENTS:
Inorganic Chemicals Calcium Phosphates Calcium Carbonate Calcium Sulfate Halites Metallic Oxides Organic Chemicals Carbohydrates Sugar Starch Cellulose Petrochemicals Glycols (alcohol) Povidones polymers Mineral Hydrocarbons Oleochemicals Gelatin (Proteins)
Fillers and diluents Binders Coatings Flavoring agents Disintegrants Colorants Others
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1053
Dry Eye Syndrome Treatment Market
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa Allied Analytics LLP 800-792-5285 email us here Visit us on social media: Facebook Twitter LinkedIn
EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.
© 1995-2022 IPD Group, Inc. dba EIN Presswire All Right Reserved.